Latest Insights - page 90 | BiopharmaTrend

How To Hunt For Drugs In Dark Chemical Matter

Pharma productivity has remained a daunting challenge, notably because R&D departments have been shuffled and reorganized over the last few years in attempts to revitalize the process. One trend, among …

Continue ›››

Converging Trends Brings Organic Electrochemistry To The Front Line Of Drug Discovery

In a case of "back to the future", chemists at Scripps collaborating with instrument engineers at IKA have unveiled a powerful tool for electrifying chemistry to achieve complex reactions. The …

Continue ›››

Combining Genomics And AI To Mine New Drug Ideas From Fungi

Boston-based LifeMine Therapeutics, a fresh new drug discovery startup, just announced a $55 million Series A financing from a number of life sciences investors, including WuXi Healthcare Ventures, Foresite Capital, …

Continue ›››

Evaxion Biotech Uses AI To Develop Anticancer And Antimicrobial Vaccines

This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from Denmark. Evaxion Biotech uses its machine learning-based platform to compare …

Continue ›››

8 Biopharma Trends and Top Startups to Follow in 2017

Pharmaceutical industry is rapidly evolving, influenced by emerging novel technologies and recent advances in Life Sciences and Big Data analysis, new government policies and regulations, and a changing market conjuncture. …

Continue ›››

Unveiling Hidden Drug Targets

Scientists estimated that the human genome encodes above 20,000 different proteins in our body. However, available public databases contain records of known ligands for only about 10% of all proteins. …

Continue ›››

Chinese Biotech Innovent Biologics, Inc. Raises USD 260M To Accelerate Biologics Development

Chinese biopharmaceutical industry investment landscape has been marked by a new record -- USD $260M Series D investment raised by Innovent Biologics, Inc. exceeded China's previous investment deals for biopharmaceutical …

Continue ›››

Learning From Nature: New Antibiotics Found In Our Body

To date, nature has been the best teacher for drug discovery scientists, especially for those who develop antimicrobial drugs. Lately, a new example proving this notion emerged in press - …

Continue ›››

A New Player In The Area Of Anti-inflammatory Therapeutics: Biotech Startup Inflazome To Tackle The Problem

Understanding and controlling inflammation processes has become a central goal in modern medical research. A number of companies developing novel anti-inflammatory drugs has emerged to grow on the wave of …

Continue ›››

A Drug Repurposing Case By Biotech Startup Forty Seven Inc

Drug repositioning is a smart and cost-effective approach used by some pharmaceutical companies to re-invent their previously successful drugs in a new role and generate extra value from existing assets. …

Continue ›››

Cross-Coupling Hits The Big Time Again

Recently, a series of papers emerged in scientific press significantly expanding capabilities of classical carbon-heteroatom cross-coupling reactions making them simpler, cheaper, and efficient across a much broader range of substrates. …

Continue ›››

A Second Chance for Integrins: Biotech Startup Morphic Therapeutic Reinvents Old Target

Integrins are a group of transmembrane receptors playing a major role in cell-cell and cell-extracellular matrix (ECM) interactions. When triggered, integrin receptors transduce signals to the interior of the cell, …

Continue ›››